Benzonatate
- Product NDC
- 70934-675
- 11-digit product format
- 709340675
- Labeler code
- 70934
- Product ID
- 70934-675_d0113967-5d31-db35-e053-2a95a90ada42
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA206948
- Marketing category
- ANDA
- Marketing start
- 2020-04-14
- Marketing end
- 2024-02-29
- Substance
- BENZONATATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-675-15 | 70934067515 | 15 CAPSULE in 1 BOTTLE, PLASTIC (70934-675-15) | 15 capsule | 2021-10-29 | 2023-12-31 | No | No | Current |
| 70934-675-20 | 70934067520 | 20 CAPSULE in 1 BOTTLE, PLASTIC (70934-675-20) | 20 capsule | 2020-04-14 | 0000-00-00 | No | No | Current |
| 70934-675-30 | 70934067530 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-675-30) | 30 capsule | 2020-04-14 | 0000-00-00 | No | No | Current |